pelvic organ prolapse
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. From January 2021 to January 2022, cases of female pelvic organ prolapse are diagnosed and treated in the Obstetrics and Gynecology Hospital of Fudan University; 2. Patients who have informed consent and will sign the informed consent; 3. Adult female; 4. Patients with symptomatic pelvic prolapse and stage III or above of POP-Q, or recurrence of stage II with above of POP-Q; 5. Patients who can be followed up for 3 years.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of pelvic radiotherapy; 2. Patients with prolapse treated by transvaginal mesh; 3. Women with fertility requirements; pregnant or lactating patients; 4. The patients with pelvic pain caused by pelvic floor muscle spasm were found under basic condition; 5. Patients with long-term use of steroid hormone in immune diseases; 6. Current smokers; 7. Patients with pain syndrome, which may lead to increased sensitivity to pelvic pain (such as fibromyalgia, bladder pain syndrome); 8. Patients who may have malignant tumors; 9. Patients who are too old to tolerate surgery or whose surgical benefits are significantly smaller than surgical trauma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| POP-Q;the quality of life questionnare; | — |
Secondary
| Measure | Time frame |
|---|---|
| complications;recurrence; | — |
Countries
China
Contacts
Obstetrics and Gynecology Hospital of Fudan University